Sermorelin, Ipamorelin, and CJC-1295 Stack: What the Research Says

The sermorelin, ipamorelin, and CJC-1295 stack is a combination of three growth hormone-releasing peptides that people use to try to raise natural growth hormone (GH) output, improve sleep, and support recovery. No published human trial has tested all three together, and none of these peptides is FDA-approved for general anti-aging or body composition use in the United States. Anyone considering the combination should review risks, dosing, and legal status with a licensed healthcare professional first.

What each peptide in the stack actually does

All three compounds encourage the pituitary to release more GH, but they act on different receptors. Sermorelin and CJC-1295 target GHRH receptors, while ipamorelin targets the ghrelin receptor. That difference is the main reason people stack them instead of using one alone.

Sermorelin is a shortened fragment of growth hormone-releasing hormone, so it copies the body's own GHRH signal. Ipamorelin is a selective ghrelin mimetic that tends to cause less cortisol release and less appetite stimulation than older peptides such as GHRP-6.

CJC-1295 is sold in two forms, and mixing them up is one of the most common errors in community discussions. CJC-1295 with DAC binds to albumin and stays active for days, while CJC-1295 without DAC is cleared in roughly half an hour.

Naming also varies by vendor. Some list the blend as sermorelin ipamorelin-cjc1295, and others describe cjc-1295/ipamorelin and sermorelin together, but the three-peptide idea is the same.

Why people combine a GHRH analog with ipamorelin

GHRH and ghrelin pathways amplify each other. In research settings, giving a GHRH analog and a ghrelin mimetic at the same time usually produces a larger GH pulse than either compound produces alone.

That synergy is the rationale behind most sermorelin and cjc-1295 stack protocols, and it is also why ipamorelin appears in nearly every version of them.

The question of can you take cjc-1295 and sermorelin together comes up constantly, and the honest answer is that it is largely redundant. Both bind GHRH receptors, so adding sermorelin to CJC-1295 mostly increases cost and side-effect exposure rather than GH output.

Dosing protocols people discuss online

Nothing in this section is a dosing recommendation. The ranges below come from community posts and older research protocols, and they vary widely between sources.

Most reported schedules involve subcutaneous injections one to three times per day, often before bed and around training. Higher doses do not automatically produce better results, and they raise the odds of water retention, hunger changes, and irritation at the injection site.

What results do people report?

Self-reported outcomes tend to cluster around deeper sleep, faster recovery, and modest body-composition changes over 8 to 12 weeks. People searching for cjc-1295 ipamorelin results before and after mostly find anecdotal timelines and photos rather than controlled data.

IGF-1, fasting glucose, and testosterone can shift when GH signaling increases, so bloodwork matters more than how someone feels. Anyone comparing notes in cjc-1295 and ipamorelin reddit threads should remember that forums are anecdotes, not clinical evidence.

Expectation also plays a role, since a nightly injection routine can feel effective regardless of what is in the vial.

Risks, side effects, and safety

Common complaints include redness at the injection site, headaches, flushing, increased appetite, and joint or muscle aching. Because these peptides raise GH and downstream IGF-1, there are theoretical concerns about insulin resistance, fluid retention, and tissue growth with long-term use.

GH-releasing peptides are generally not recommended during pregnancy and may be inappropriate for people with diabetes, a history of cancer, or pituitary disease. A clinician should review medication interactions and monitor lab work over time.

Sermorelin's FDA-approved diagnostic product was discontinued in the United States in 2008, and compounded sermorelin is not FDA-approved for anti-aging use. That gap between marketing claims and approval status is worth keeping in mind.

Legal status and sourcing reality

In the United States, CJC-1295 and ipamorelin are sold as research chemicals and are not approved for human use. Sermorelin is available only with a prescription through specific compounding channels, and promoting it for anti-aging or weight loss is not permitted.

Buying from unverified vendors carries real risk, including mislabeled vials, incorrect concentrations, and contamination found in independent testing. A certificate of analysis supplied by the seller is not the same as third-party verification.

Searches for tesamorelin and cjc-1295 stack lead to similar questions, although tesamorelin is the only compound in this family with an FDA-approved indication, and that indication is limited to HIV-associated lipodystrophy.

Bottom line

The sermorelin, ipamorelin, and CJC-1295 stack has a plausible mechanism, thin human evidence, and no FDA approval for fitness or anti-aging purposes. Stacking sermorelin with CJC-1295 adds little because both compounds act on the same receptor.

If you choose to explore GH-releasing peptides, do it with a physician's oversight, baseline and follow-up lab work, and realistic expectations about what these compounds can and cannot do.